Literature DB >> 29242248

Causes of Death after a Hospitalization with AKI.

Samuel A Silver1, Ziv Harel2,3,4, Eric McArthur4, Danielle M Nash4, Rey Acedillo5, Abhijat Kitchlu2, Amit X Garg4,5, Glenn M Chertow6, Chaim M Bell4,7,8, Ron Wald2,3,4.   

Abstract

Mortality after AKI is high, but the causes of death are not well described. To better understand causes of death in patients after a hospitalization with AKI and to determine patient and hospital factors associated with mortality, we conducted a population-based study of residents in Ontario, Canada, who survived a hospitalization with AKI from 2003 to 2013. Using linked administrative databases, we categorized cause of death in the year after hospital discharge as cardiovascular, cancer, infection-related, or other. We calculated standardized mortality ratios to compare the causes of death in survivors of AKI with those in the general adult population and used Cox proportional hazards modeling to estimate determinants of death. Of the 156,690 patients included, 43,422 (28%) died in the subsequent year. The most common causes of death were cardiovascular disease (28%) and cancer (28%), with respective standardized mortality ratios nearly six-fold (5.81; 95% confidence interval [95% CI], 5.70 to 5.92) and eight-fold (7.87; 95% CI, 7.72 to 8.02) higher than those in the general population. The highest standardized mortality ratios were for bladder cancer (18.24; 95% CI, 17.10 to 19.41), gynecologic cancer (16.83; 95% CI, 15.63 to 18.07), and leukemia (14.99; 95% CI, 14.16 to 15.85). Along with older age and nursing home residence, cancer and chemotherapy strongly associated with 1-year mortality. In conclusion, cancer-related death was as common as cardiovascular death in these patients; moreover, cancer-related deaths occurred at substantially higher rates than in the general population. Strategies are needed to care for and counsel patients with cancer who experience AKI.
Copyright © 2018 by the American Society of Nephrology.

Entities:  

Keywords:  acute renal failure; cancer; cardiovascular

Mesh:

Year:  2017        PMID: 29242248      PMCID: PMC5827605          DOI: 10.1681/ASN.2017080882

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  38 in total

1.  Problems with proper completion and accuracy of the cause-of-death statement.

Authors:  A E Smith Sehdev; G M Hutchins
Journal:  Arch Intern Med       Date:  2001-01-22

2.  Incidence, outcomes, and comparisons across definitions of AKI in hospitalized individuals.

Authors:  Xiaoxi Zeng; Gearoid M McMahon; Steven M Brunelli; David W Bates; Sushrut S Waikar
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-31       Impact factor: 8.237

3.  Performance and limitations of administrative data in the identification of AKI.

Authors:  Morgan E Grams; Sushrut S Waikar; Blaithin MacMahon; Seamus Whelton; Shoshana H Ballew; Josef Coresh
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-23       Impact factor: 8.237

Review 4.  Multiple facets of macrophages in renal injury.

Authors:  David C Kluth; Lars-Peter Erwig; Andrew J Rees
Journal:  Kidney Int       Date:  2004-08       Impact factor: 10.612

5.  Cancer Mortality Among Recipients of Solid-Organ Transplantation in Ontario, Canada.

Authors:  Sergio A Acuna; Kimberly A Fernandes; Corinne Daly; Lisa K Hicks; Rinku Sutradhar; S Joseph Kim; Nancy N Baxter
Journal:  JAMA Oncol       Date:  2016-04       Impact factor: 31.777

6.  Association between AKI, recovery of renal function, and long-term outcomes after hospital discharge.

Authors:  Neesh Pannu; Matthew James; Brenda Hemmelgarn; Scott Klarenbach
Journal:  Clin J Am Soc Nephrol       Date:  2012-11-02       Impact factor: 8.237

Review 7.  Impact of acute kidney injury on distant organ function: recent findings and potential therapeutic targets.

Authors:  Kent Doi; Hamid Rabb
Journal:  Kidney Int       Date:  2016-01-16       Impact factor: 10.612

8.  Defining the cause of death in hospitalised patients with acute kidney injury.

Authors:  Nicholas M Selby; Nitin V Kolhe; Christopher W McIntyre; John Monaghan; Nigel Lawson; David Elliott; Rebecca Packington; Richard J Fluck
Journal:  PLoS One       Date:  2012-11-02       Impact factor: 3.240

9.  The real importance of pre-existing comorbidities on long-term mortality after acute kidney injury.

Authors:  Mariana B Pereira; Dirce M T Zanetta; Regina C R M Abdulkader
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

10.  Increased risk of active tuberculosis following acute kidney injury: a nationwide, population-based study.

Authors:  Vin-Cent Wu; Chen-Yi Wang; Chih-Chung Shiao; Chia-Hsui Chang; Hui-Yu Huang; Tao-Min Huang; Chun-Fu Lai; Meng-Chun Lin; Wen-Je Ko; Kwan-Dun Wu; Chong-Jen Yu; Chin-Chung Shu; Chih-Hsin Lee; Jann-Yuan Wang
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

View more
  22 in total

Review 1.  Long-Term Outcomes in Patients with Acute Kidney Injury.

Authors:  Rebecca A Noble; Bethany J Lucas; Nicholas M Selby
Journal:  Clin J Am Soc Nephrol       Date:  2020-02-19       Impact factor: 8.237

Review 2.  Long-term outcomes of acute kidney injury and strategies for improved care.

Authors:  Matthew T James; Meha Bhatt; Neesh Pannu; Marcello Tonelli
Journal:  Nat Rev Nephrol       Date:  2020-02-12       Impact factor: 28.314

3.  Penicilliumin B Protects against Cisplatin-Induced Renal Tubular Cell Apoptosis through Activation of AMPK-Induced Autophagy and Mitochondrial Biogenesis.

Authors:  Weiwei Shen; Nan Jia; Jinhua Miao; Shuangqin Chen; Shan Zhou; Ping Meng; Xuefeng Zhou; Lan Tang; Lili Zhou
Journal:  Kidney Dis (Basel)       Date:  2021-04-01

4.  Patient-Reported Experiences after Acute Kidney Injury across Multiple Health-Related Quality-of-Life Domains.

Authors:  Galen E Switzer; Chethan M Puttarajappa; Sandra L Kane-Gill; Linda F Fried; Kaleab Z Abebe; John A Kellum; Manisha Jhamb; Jessica G Bruce; Vidya Kuniyil; Paul T Conway; Richard Knight; John Murphy; Paul M Palevsky
Journal:  Kidney360       Date:  2021-12-08

5.  Urinary Trace Elements Are Biomarkers for Early Detection of Acute Kidney Injury.

Authors:  David S Gardner; Jennifer C Allen; Deborah Goodson; Daniel Harvey; Andrew Sharman; Henry Skinner; Adam Szafranek; John S Young; Elizabeth H Bailey; Mark A J Devonald
Journal:  Kidney Int Rep       Date:  2022-04-29

Review 6.  Community Health Care Quality Standards to Prevent Acute Kidney Injury and Its Consequences.

Authors:  Samuel A Silver; Mitra K Nadim; Donal J O'Donoghue; Francis P Wilson; John A Kellum; Ravindra L Mehta; Claudio Ronco; Kianoush Kashani; Mitchell H Rosner; Michael Haase; Andrew J P Lewington
Journal:  Am J Med       Date:  2019-12-10       Impact factor: 4.965

Review 7.  Acute kidney injury.

Authors:  John A Kellum; Paola Romagnani; Gloria Ashuntantang; Claudio Ronco; Alexander Zarbock; Hans-Joachim Anders
Journal:  Nat Rev Dis Primers       Date:  2021-07-15       Impact factor: 52.329

Review 8.  Recent Advances in Models, Mechanisms, Biomarkers, and Interventions in Cisplatin-Induced Acute Kidney Injury.

Authors:  Sara J Holditch; Carolyn N Brown; Andrew M Lombardi; Khoa N Nguyen; Charles L Edelstein
Journal:  Int J Mol Sci       Date:  2019-06-20       Impact factor: 5.923

9.  Acute kidney injury calculated using admission serum creatinine underestimates 30-day and 1-year mortality after acute stroke.

Authors:  Julia Arnold; Don Sims; Paramjit Gill; Paul Cockwell; Charles Ferro
Journal:  Clin Kidney J       Date:  2019-05-10

10.  Risk factors for major adverse kidney events in the first year after acute kidney injury.

Authors:  Emily J See; Nigel D Toussaint; Michael Bailey; David W Johnson; Kevan R Polkinghorne; Raymond Robbins; Rinaldo Bellomo
Journal:  Clin Kidney J       Date:  2019-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.